Top Markets
Coin of the day
VISEN Pharmaceuticals VISEN Pharmaceuticals

VISEN Pharmaceuticals

2561
Classifica tra le azioni #16882
VISEN Pharmaceuticals operates as an investment holding company, concentrating... VISEN Pharmaceuticals operates as an investment holding company, concentrating on the development and commercialization of endocrine treatments across mainland China, Hong Kong, and Taiwan. Their flagship product, Lonapegsomatropin, offers a once-weekly, long-acting growth hormone replacement designed for pediatric growth hormone deficiency. The company is also progressing other therapies, such as TransCon CNP (navepegritide), a long-acting prodrug utilizing c-type natriuretic peptide for achondroplasia, and Palopegteriparatide, a daily parathyroid hormone replacement therapy intended for chronic hypoparathyroidism. VISEN has forged strategic collaborations with Shanghai Pharmaceutical and United Family Healthcare. The enterprise was founded in 2018 and is based in Suzhou, China.
Prezzo delle azioni
$2.52
Capitalizzazione di mercato
$274.65M
Variazione (1 giorno)
0.46%
Variazione (1 anno)
-56.11%
Paese
CN
Scambia VISEN Pharmaceuticals (2561)

Categoria

Storico del prezzo dell'azione per VISEN Pharmaceuticals (2561)
Prezzo di chiusura più alto: $2.51 il 2026-09-01

Prezzo di chiusura più basso: $7.66 il 2025-03-01
Storico del prezzo dell'azione di VISEN Pharmaceuticals dal 2025 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) -15.85%
2025 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$171.67 -
DE
$165.71 31.84%
DE
$38.13 25.43%
JP
$21.28 19.63%
IN
$215.70 26.53%
CH